van Beers EJ - Search Results

1

One-year safety and efficacy of mitapivat in sickle cell disease: follow-up results of a phase 2, open-label study.

van Dijk MJ, Rab MAE, van Oirschot BA, Bos J, Derichs C, Rijneveld AW, Cnossen MH, Nur E, Biemond BJ, Bartels M, Jans JJM, van Solinge WW, Schutgens REG, van Wijk R, van Beers EJ. van Dijk MJ, et al. Among authors: van beers ej. Blood Adv. 2023 Dec 26;7(24):7539-7550. doi: 10.1182/bloodadvances.2023011477. Blood Adv. 2023. PMID: 37934880 Free PMC article. Clinical Trial.

2

Licorice consumption as a cause of posterior reversible encephalopathy syndrome: a case report.

van Beers EJ, Stam J, van den Bergh WM. van Beers EJ, et al. Among authors: van den bergh wm. Crit Care. 2011;15(1):R64. doi: 10.1186/cc10040. Epub 2011 Feb 18. Crit Care. 2011. PMID: 21332974 Free PMC article.

3

Extensive slow-flow vascular malformations and pulmonary hypertension.

van Beers EJ, Douma RA, Oduber CE, Gerdes VE, van der Horst CM, Bresser P. van Beers EJ, et al. Among authors: van der horst cm. Arch Dermatol. 2010 Dec;146(12):1416-8. doi: 10.1001/archdermatol.2010.377. Arch Dermatol. 2010. PMID: 21173324 No abstract available.

4

Acute sinusitis and blindness as the first presentation of chronic lymphocytic leukaemia.

Lim KH, Thomas G, van Beers EJ, Hosman AE, Mourits MP, van Noesel CJ, Kater AP, Reinartz SM. Lim KH, et al. Among authors: van noesel cj, van beers ej. Neth J Med. 2014 Dec;72(10):548-50. Neth J Med. 2014. PMID: 26219762 Free article.

5

[Pathophysiology and treatment of sickle-cell disease].

van Beers EJ, Peters M, Biemond BJ. van Beers EJ, et al. Ned Tijdschr Geneeskd. 2005 May 21;149(21):1144-9. Ned Tijdschr Geneeskd. 2005. PMID: 15940917 Review. Dutch.

6

Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial.

van Beers EJ, van Tuijn CF, Nieuwkerk PT, Friederich PW, Vranken JH, Biemond BJ. van Beers EJ, et al. Among authors: van tuijn cf. Am J Hematol. 2007 Nov;82(11):955-60. doi: 10.1002/ajh.20944. Am J Hematol. 2007. PMID: 17617790 Free article. Clinical Trial.

7

Large and medium-sized pulmonary artery obstruction does not play a role of primary importance in the etiology of sickle-cell disease-associated pulmonary hypertension.

van Beers EJ, van Eck-Smit BL, Mac Gillavry MR, van Tuijn CF, van Esser JW, Brandjes DP, Kappers-Klunne MC, Duits AJ, Biemond BJ, Schnog JJ; CURAMA Study Group. van Beers EJ, et al. Among authors: van esser jw, van tuijn cf, van eck smit bl. Chest. 2008 Mar;133(3):646-52. doi: 10.1378/chest.07-1694. Epub 2008 Jan 15. Chest. 2008. PMID: 18198257

8

Sickle cell patients are characterized by a reduced glycocalyx volume.

van Beers EJ, Nieuwdorp M, Duits AJ, Evers LM, Schnog JJ, Biemond BJ; CURAMA Study Group. van Beers EJ, et al. Haematologica. 2008 Feb;93(2):307-8. doi: 10.3324/haematol.12027. Haematologica. 2008. PMID: 18245656 Free article.

9

Sickle cell disease-related organ damage occurs irrespective of pain rate: implications for clinical practice.

van Beers EJ, van Tuijn CF, Mac Gillavry MR, van der Giessen A, Schnog JJ, Biemond BJ; CURAMA study group. van Beers EJ, et al. Among authors: van der giessen a, van tuijn cf. Haematologica. 2008 May;93(5):757-60. doi: 10.3324/haematol.12152. Epub 2008 Mar 26. Haematologica. 2008. PMID: 18367483 Free article.

10

Normal sublingual microcirculation during painful crisis in sickle cell disease.

van Beers EJ, Goedhart PT, Unger M, Biemond BJ, Ince C. van Beers EJ, et al. Microvasc Res. 2008 May;76(1):57-60. doi: 10.1016/j.mvr.2008.02.001. Epub 2008 Mar 12. Microvasc Res. 2008. PMID: 18423765

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

101 results

Search Page